The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Screening for CKD with eGFR: Doubts and Dangers
Open accessAbstract
The early identification of chronic kidney disease (CKD) is a legitimate enterprise if it provides meaningful opportunities for effective and safe interventions that reduce the risk of death, end-stage renal disease, or complications of renal dysfunction. The screening of unselected populations not already known to be at risk of CKD has the potential of harm and has not been shown to be cost-effective. The application of formulas for the estimation of GFR (eGFR) to the guidelines for staging of chronic kidney disease (Kidney Disease Outcomes Quality Initiative, K/DOQI) as universal screening tools is of dubious value and has inherent dangers. This conclusion is based both on the unreliability of current formulas for determining eGFR and flaws in the K/DOQI schema for staging of CKD. The failure to take into account the normal age- and gender- associated decline in GFR and the lack of a requirement for other evidence of kidney disease in CKD stage 3 leads to an erroneous categorization of large numbers of mostly elderly and female subjects as having an intermediate stage of a lethal disease. Criteria for CKD staging should take into account the percentile distribution of eGFR by age and gender. Targeted screening for CKD is likely to be more cost-effective than universal screening. Whether early identification and treatment of subjects with "reduced" levels of GFR within the normal range for their age/gender, but without any other manifestations of kidney disease, will reduce the subsequent risk of cardiovascular events or progression to end-stage-renal disease is currently unproven.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369
Prevalence of Chronic Kidney Disease in the United States
Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., & Levey, A. S. (2007) · JAMA · doi:10.1001/jama.298.17.2038 · Cited by 4,895
Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
Stevens, L. A., Coresh, J., Greene, T., & Levey, A. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra054415 · Cited by 2,952
A comparative evaluation of various methods for microalbuminuria screening
Sarafidis, P. A., Riehle, J., Bogojevic, Z., Basta, E., Chugh, A., & Bakris, G. L. (2008) · American Journal of Nephrology · doi:10.1159/000111825 · Cited by 41
Cited by
Early recognition and prevention of chronic kidney disease
James, M. T., Hemmelgarn, B. R., & Tonelli, M. (2010) · The Lancet · doi:10.1016/s0140-6736(09)62004-3 · Cited by 606
Nitsch, D., Grams, M., Sang, Y., Black, C., Cirillo, M., Djurdjev, O., Iseki, K., Jassal, S. K., Kimm, H., Kronenberg, F., et al. (2013) · BMJ · doi:10.1136/bmj.f324 · Cited by 477
Stevens, L. A., Li, S., Wang, C., Huang, C., Becker, B. N., Bomback, A. S., Brown, W. W., Burrows, N. R., Jurkovitz, C. T., McFarlane, S. I., et al. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.09.035 · Cited by 281
Early chronic kidney disease: diagnosis, management and models of care
Wouters, O. J., O'Donoghue, D. J., Ritchie, J., Kanavos, P. G., & Narva, A. S. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.85 · Cited by 258
Metadata
- Authors
- Glassock, R. J., & Winearls, C.
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2008-09
- Volume
- 3
- Issue
- 5
- Pages
- 1563-1568
- ISSN
- 1555-9041 (ISSN-L)
- OpenAlex
- W2104620275
- Cited by
- 178
- References
- 5
- FWCI
- 18.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Screening for CKD with eGFR: Doubts and Dangers. https://app.cochat.ai/papers/10.2215/cjn.00960208
- The paper
- Glassock, R. J., & Winearls, C. (2008). Screening for CKD with eGFR: Doubts and Dangers. Clinical Journal of the American Society of Nephrology. https://doi.org/10.2215/cjn.00960208
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.